VINCENT LIOU: Open Payments
NPI 1427584473 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 132 payments from 27 companies in 2025. Trend: 2023 $1,889 · 2024 $210 · 2025 $2,694
Food & beverage: $2,694
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $337 |
| Madrigal Pharmaceuticals | 3 | $230 |
| Amneal Pharmaceuticals LLC | 21 | $216 |
| Dexcom, Inc. | 8 | $188 |
| Sequel Med Tech, LLC | 3 | $187 |
| Corcept Therapeutics | 9 | $174 |
| Amgen Inc. | 12 | $156 |
| Radius Health, Inc. | 6 | $127 |
| Ascendis Pharma Endocrinology Inc | 5 | $121 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $116 |
Products named: REZDIFFRA, UNITHROID, JARDIANCE, Dexcom G6 Transmitter, TWIIST, Korlym, Yorvipath, ISTURISA.
Industry payments across AZ — which companies pay providers there.
